Our Mission

We are committed to improving the lives of cancer patients by supporting the development and commercialization of innovative technology for screening cancer drugs against the most invasive Stem Cell sub-population of cancer cells.

Our Team

Dr. Mohan Venkataramana

President & Chief Technology Officer

Dr. Mohan Venkataramana is a serial entrepreneur and has experience building solutions and companies for niche areas in multiple verticals that include Life Sciences and Healthcare, Clean Energy, Retail Services, Telecommunications, Software and Enterprise solutions, Big data, Cloud Computing and Mobile Solutions. He focuses on identifying the current and future trends in emerging areas of technology, and creating new technologies to help bridge the gap to the future. Mohan is a graduate of MIT, Indian Institute of Technology and University of Illinois in Chemical Engineering. He has worked at AT&T Bell Labs, Fred Hutchinson Cancer Research Center, Microsoft and Amazon. Mohan is passionate about helping people reach their full potential and has mentored several entrepreneurs and students.


Mr. Saravanan Dhandapani

Chief Operations Officer

Mr. Saravanan Dhandapani has over 20 years of successfully managing applications development and various teams in product development and operations.


Prof. Esmaiel Jabbari

Consultant

Prof. Esmaiel Jabbari is a Professor of Chemical and Biomedical Engineering at the University of South Carolina, and is the inventor of the technologies on which OncoStemCell technology is based. For his CV, detailing his extensive academic and research capabilities, please visit CV of Prof. Jabbari. He has received numerous awards including the Berton Rahn Award from the AO Foundation in 2012, the Stephen Milam Award from the Oral and Maxillofacial Surgery Foundation in 2008, and election to the College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE) in 2013. The principal scientist has published >250 books, book chapters, journal articles, and conference proceedings on bioscaffolds and he has participated as a speaker in >260 seminars at National and International Conferences. He has given >70 keynote and invited speeches at joint academic-industry conferences and he has trained >130 engineers and scientists on the design and testing of bioscaffolds. The principal scientist has been a member of numerous scientific organizations including the Society for Biomaterials (SFB), Biomedical Engineering Society (BMES), Engineering in Medicine and Biology Society (EMBS), and Tissue Engineering and Regenerative Medicine International Society (TERMIS).